Purchase by Richard Williams of 1000 shares of HomeTrust Bancshares
About 67% of ProKidney Corp's investor base is looking to short. The analysis of overall sentiment of trading ProKidney Corp stock suggests that many investors are alarmed at this time. ProKidney Corp's investing sentiment shows overall attitude of investors towards ProKidney Corp.
ProKidney |
Filed transaction by Hometrust Bancshares Inc director. General open market or private purchase of non-derivative or derivative security
Read at macroaxis.com
ProKidney Corp Fundamental Analysis
We analyze ProKidney Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProKidney Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProKidney Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
ProKidney Corp is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
ProKidney Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProKidney Corp stock to make a market-neutral strategy. Peer analysis of ProKidney Corp could also be used in its relative valuation, which is a method of valuing ProKidney Corp by comparing valuation metrics with similar companies.
Peers
ProKidney Corp Related Equities
BDTX | Black Diamond | 16.52 | ||||
STOK | Stoke Therapeutics | 2.24 | ||||
RVMD | Revolution Medicines | 1.89 | ||||
EWTX | Edgewise Therapeutics | 0.91 | ||||
ACLX | Arcellx | 1.08 | ||||
PLRX | Pliant Therapeutics | 1.36 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Tools for ProKidney Stock
When running ProKidney Corp's price analysis, check to measure ProKidney Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProKidney Corp is operating at the current time. Most of ProKidney Corp's value examination focuses on studying past and present price action to predict the probability of ProKidney Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProKidney Corp's price. Additionally, you may evaluate how the addition of ProKidney Corp to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
CEOs Directory Screen CEOs from public companies around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |